ID: ALA5278938

Max Phase: Preclinical

Molecular Formula: C19H18N2+2

Molecular Weight: 274.37

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(-c2cc[n+]3c(c2)-c2cccc[n+]2CC3)cc1

Standard InChI:  InChI=1S/C19H18N2/c1-15-5-7-16(8-6-15)17-9-11-21-13-12-20-10-3-2-4-18(20)19(21)14-17/h2-11,14H,12-13H2,1H3/q+2

Standard InChI Key:  YQQZJBPJBIUSRP-UHFFFAOYSA-N

Associated Targets(non-human)

Calf thymus DNA 4845 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 274.37Molecular Weight (Monoisotopic): 274.1459AlogP: 2.92#Rotatable Bonds: 1
Polar Surface Area: 7.76Molecular Species: NEUTRALHBA: 0HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: -4.87CX LogD: -4.87
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.60Np Likeness Score: -0.20

References

1. Tomczyk MD, Walczak KZ..  (2018)  l,8-Naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017.,  159  [PMID:30312931] [10.1016/j.ejmech.2018.09.055]

Source